Brief: Redwood Pharma Rights Issue Significantly Oversubscribed

Redwood Pharma AB

27/09/2019 07:32

Sept 27 (Reuters) - Redwood Pharma  REDWPH.TE :  
    * CO'S BOARD OF DIRECTORS ANNOUNCED ON THURSDAY RESULTS OF
NEW
RIGHTS ISSUE
    * ISSUE WAS OVERSUBSCRIBED BY 591%
    * ISSUE BRINGS PROCEEDS OF ABOUT SEK 11.5 MLN BEFORE ISSUE
COSTS
OF ABOUT SEK 0.3 MLN
    * BOARD PLANS TO CARRY OUT DIRECTED ISSUE OF 428,620 SHARES
AT SEK
7.25 PER SHARE TO OFFSET BRIDGE LOANS FROM WILHELM RISBERG AND
FREDRIK LUNDGREN

    
Source text for Eikon:  ID:nNDL2KM2J6 
    
Further company coverage:  REDWPH.TE  
   
    
    

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 7720920;))